The impact of Covid-19 in patients with chronic myeloid leukemia-a nationwide population-based study
Leukemia
.
2023 May;37(5):1156-1159.
doi: 10.1038/s41375-023-01893-1.
Epub 2023 Apr 10.
Authors
Torsten Dahlén
1
2
,
Hjalmar Flygt
3
,
Anna Lübking
4
,
Ulla Olsson-Strömberg
3
,
Lovisa Wennström
5
,
Arta Dreimane
6
,
Anders Själander
7
,
Susannah Leach
8
9
,
Magnus Gisslén
10
11
,
Huiqi Li
12
,
Martin Höglund
3
,
Leif Stenke
13
,
Fredrik Nyberg
12
Affiliations
1
Department of Medicine Solna, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
[email protected]
.
2
Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
[email protected]
.
3
Department of Medical Science and Division of Hematology, University Hospital, Uppsala, Sweden.
4
Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden.
5
Section of Hematology, Sahlgrenska University Hospital, Gothenburg, Sweden.
6
Department of Hematology, Linköping University Hospital, Linköping, Sweden.
7
Department of Public Health and Clinical Medicine, Umeå University, Sundsvall, Sweden.
8
Department of Clinical Pharmacology, Sahlgrenska University Hospital, Gothenburg, Sweden.
9
Department of Microbiology and Immunology, Institute of Biomedicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
10
Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
11
Department of Infectious Diseases, Region Västra Götaland, Sahlgrenska University Hospital, Gothenburg, Sweden.
12
School of Public health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
13
Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
PMID:
37037908
PMCID:
PMC10088575
DOI:
10.1038/s41375-023-01893-1
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19* / epidemiology
Chronic Disease
Humans
Leukemia, Myelogenous, Chronic, BCR-ABL Positive* / epidemiology
Leukemia, Myeloid*